Sentences with phrase «state financial aid programs»
Office of Student Financial Assistance > State Financial Aid Programs > Massachusetts Loan Repayment Program (MLRP) for Health Professionals
http://www.mass.edu/
Office of Student Financial Assistance > State Financial Aid Programs > Massachusetts Educational Financing Authority (MEFA) Prepaid Tuition Waiver Program
Office of Student Financial Assistance > State Financial Aid Programs > DCF Adopted Child Tuition Waiver and Fee Assistance Program
Office of Student Financial Assistance > State Financial Aid Programs > Paul Tsongas Scholarship
Office of Student Financial Assistance > State Financial Aid Programs > Early Childhood Educators Scholarship Program
Office of Student Financial Assistance > State Financial Aid Programs > MassTransfer Tuition Credit Program
Office of Student Financial Assistance > State Financial Aid Programs > Massachusetts No Interest Loan Program
Office of Student Financial Assistance > State Financial Aid Programs > Career Advancement Program Tuition Waiver
Office of Student Financial Assistance > State Financial Aid Programs > Commonwealth Hurricane Katrina Emergency Tuition Waiver
Office of Student Financial Assistance > State Financial Aid Programs > Collaborative Teachers Tuition Waiver
Office of Student Financial Assistance > State Financial Aid Programs > Christian A. Herter Memorial Scholarship Program
Office of Student Financial Assistance > State Financial Aid Programs > Graduate Tuition Waiver
Office of Student Financial Assistance > State Financial Aid Programs > One Family Scholarship Program
Office of Student Financial Assistance > State Financial Aid Programs > LEADA@Liberty Scholarship
Office of Student Financial Assistance > State Financial Aid Programs > High Technology Scholar / Intern Tuition Waiver
Office of Student Financial Assistance > State Financial Aid Programs > Paraprofessional Teacher Preparation Grant Program
Office of Student Financial Assistance > State Financial Aid Programs > John and Abigail Adams Scholarship
Office of Student Financial Assistance > State Financial Aid Programs > Valedictorian Program Tuition Waiver
Office of Student Financial Assistance > State Financial Aid Programs > Stanley Z. Koplik Certificate of Mastery Tuition Waiver Program
The Free Application for Federal Student Aid (FAFSA) is used each year to determine your eligibility for federal financial aid programs as well as some state financial aid programs.
In contrast to the byzantine system of federal and state financial aid programs, free college is a very easy concept to understand.
Cuomo didn't offer more details about the plan, which would rely on existing federal and state financial aid programs, while adding $ 163 million in state tax dollars for Excelsior Scholarships that pay for tuition costs not covered by the traditional aid programs.
Had it passed, New York would have become the fifth state to enact the DREAM Act, which would have allowed state financial aid programs to cover the college kids of undocumented immigrants.
In addition, the governor proposes no broad - based increases in state financial aid programs, thus leaving either the student, or the college, short.
New York's state financial aid program for low - income students is already one of the most generous in the nation, officials say.
Office of Student Financial Assistance > State Financial Aid Program > Need - Based Tuition Waiver Program
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Financial aid is available, and Elementary and Early Childhood program students have the option to apply their Sunbridge education toward earning a fully - accredited MEd through our partnership with The State University of New York's Empire State College.
An important step would be to ensure that state financial aid opportunities, such as the Tuition Assistance Program (TAP), are available to undocumented immigrants who came to the U.S. as children.
Many schools plan to add new student programs and services next year, aided by millions of dollars in fresh financial assistance from Albany, as well as reductions in state pension costs.
The Higher Education Services Corporation, which runs the state's Excelsior Scholarship, Tuition Assistance Program (TAP) and other financial aid programs, would get an increase of $ 80 million — 7.3 percent — to $ 1.18 billion.
Students, labor leaders, and citizens» groups are calling on the State Senate to pass the New York DREAM Act, which would give undocumented youth access to state financial aid like the Tuition Assistance ProState Senate to pass the New York DREAM Act, which would give undocumented youth access to state financial aid like the Tuition Assistance Prostate financial aid like the Tuition Assistance Program.
Sponsored by Assemblymember Carmen De La Rosa of Manhattan, the measure would allow students brought into the country as children to seek state financial aid for higher education, including the Excelsior Scholarship program that makes tuition at state colleges free for low - income and middle - class students.
He does propose to expand financial aid to those college students who are undocumented immigrants, but he proposes no expansions in the state's Tuition Assistance Program, which provides benefits to all students in need.
Money from the fund supports some of the state's most important safety net programs --» the State's Medicaid program, Family Health Plus, workforce recruitment and retention, the Elderly Pharmaceutical Insurance Coverage (EPIC) program, Child Health Plus (CHP), Graduate Medical Education, AIDS programs, disproportionate share payments to hospitals and other various public health initiatives,» according to the state's financial state's most important safety net programs --» the State's Medicaid program, Family Health Plus, workforce recruitment and retention, the Elderly Pharmaceutical Insurance Coverage (EPIC) program, Child Health Plus (CHP), Graduate Medical Education, AIDS programs, disproportionate share payments to hospitals and other various public health initiatives,» according to the state's financial State's Medicaid program, Family Health Plus, workforce recruitment and retention, the Elderly Pharmaceutical Insurance Coverage (EPIC) program, Child Health Plus (CHP), Graduate Medical Education, AIDS programs, disproportionate share payments to hospitals and other various public health initiatives,» according to the state's financial state's financial plan.
«They tend to be relatively cost - effective for sponsoring governments because each of the programs use a «last - dollar» model whereby the state subsidizes tuition costs after the student has exhausted all other available state and federal financial aid.»
The act would open access to financial aid through the taxpayer - funded Tuition Assistance Program, or TAP, for immigrants known as «Dreamers» — those brought to the United States or who stayed on expired visas when they were minors.
Students from across the state are gathering in Albany today to encourage elected officials to commit more resources to student financial aid programs.
Cuomo also supports extending state college financial aid programs to students without legal status.
She has instead sponsored several bills to expand the state's Tuition Assistance Program and other existing streams of financial aid for college students who are citizens.
State departments of education and colleges offering the programs can provide information on financial aid, and some states, such as Minnesota and North Dakota, have loan repayment programs for teachers willing to work in areas of critical need.
Reporting from Berlin, Vogel wrote «that the federal government will take over the full cost of the country's financial aid program for university students — which will amount to a $ 1.2 billion savings for state budgets each year.»
At a meeting on Monday evening, Angela Merkel and leaders of her party's coalition partners agreed that the federal government will take over the full cost of the country's financial aid program for university students — which will amount to a $ 1.2 billion savings for state budgets each year.
In January, the Florida Supreme Court dismissed a legal challenge to the state's Tax Credit Scholarship Program, thereby preserving financial aid opportunities for thousands of low - income students to attend private schools.
During their time in EMERGE, our students set long - term goals, attend SAT preparation classes, take out - of - state college tours, work one - on - one with a program manager through the application process, and attend weekend workshops on interviewing, financial aid, and the transition to college.
He noted that the program did not make participants eligible for financial aid or in - state tuition in every state.
Ohio State's program selects promising minority students in grades six through eight and offers them career and cultural programs, summer institutes, tutoring, and financial aid if they do well and choose to enter OSU.
The Office of Funding and Financial Reporting (OFFR) has two primary functions: (1) Calculation and distribution of funds provided through the Florida Education Finance Program (FEFP) and state categorical aid programs such as pupil transportation; and (2) Financial reporting of school districts.
Some of her projects have included: «Improving Access to College Information and Financial Aid,» a study on the effects of simplifying the financial aid application process; «Understanding Barriers and Examining Interventions,» a series of research studies focused on college enrollment and completion for the Bill and Melinda Gates Foundation; and «Addressing the Problem of Insufficient High School Preparation,» which focuses on state efforts to regulate college remedial programs and reforms that attempt to reduce the need for remFinancial Aid,» a study on the effects of simplifying the financial aid application process; «Understanding Barriers and Examining Interventions,» a series of research studies focused on college enrollment and completion for the Bill and Melinda Gates Foundation; and «Addressing the Problem of Insufficient High School Preparation,» which focuses on state efforts to regulate college remedial programs and reforms that attempt to reduce the need for remediatiAid,» a study on the effects of simplifying the financial aid application process; «Understanding Barriers and Examining Interventions,» a series of research studies focused on college enrollment and completion for the Bill and Melinda Gates Foundation; and «Addressing the Problem of Insufficient High School Preparation,» which focuses on state efforts to regulate college remedial programs and reforms that attempt to reduce the need for remfinancial aid application process; «Understanding Barriers and Examining Interventions,» a series of research studies focused on college enrollment and completion for the Bill and Melinda Gates Foundation; and «Addressing the Problem of Insufficient High School Preparation,» which focuses on state efforts to regulate college remedial programs and reforms that attempt to reduce the need for remediatiaid application process; «Understanding Barriers and Examining Interventions,» a series of research studies focused on college enrollment and completion for the Bill and Melinda Gates Foundation; and «Addressing the Problem of Insufficient High School Preparation,» which focuses on state efforts to regulate college remedial programs and reforms that attempt to reduce the need for remediation.
Any direct or indirect erosion of Impact Aid through a voucher program will reduce the Impact Aid funding currently going to these districts, and would also place a great financial burden on the local community, which would be left to fund public schools with an already low level of state and local tax revenue.